<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-12909R2</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0009348</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Neuroscience</subject><subject>Genetics and Genomics/Complex Traits</subject><subject>Neuroscience/Cognitive Neuroscience</subject></subj-group></article-categories><title-group><article-title>Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance</article-title><alt-title alt-title-type="running-head"><italic>DRD2</italic> and Prefrontal Activity</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bertolino</surname><given-names>Alessandro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Taurisano</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pisciotta</surname><given-names>Nicola Marco</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Blasi</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fazio</surname><given-names>Leonardo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Romano</surname><given-names>Raffaella</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gelao</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bianco</surname><given-names>Luciana Lo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lozupone</surname><given-names>Madia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Di Giorgio</surname><given-names>Annabella</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Caforio</surname><given-names>Grazia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sambataro</surname><given-names>Fabio</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Niccoli-Asabella</surname><given-names>Artor</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Papp</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ursini</surname><given-names>Gianluca</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sinibaldi</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Popolizio</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sadee</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rubini</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Psychiatric Neuroscience Group, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Neuroradiology, IRCCS &#x0201c;Casa Sollievo della Sofferenza&#x0201d;, San Giovanni Rotondo, Italy</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Nuclear Medicine Unit, Department of Internal Medicine and of Public Medicine, University of Bari, Bari, Italy</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Program in Pharmacogenomics, Department of Pharmacology, College of Medicine, and Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio, United States of America</addr-line></aff><aff id="aff6"><label>6</label><addr-line>IRCCS CSS-Mendel Institute, Rome, Italy</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Department of Experimental Medicine, Sapienza University, Rome, Italy</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Aleman</surname><given-names>Andr&#x000e9;</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Groningen, Netherlands</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>a.bertolino@psichiat.uniba.it</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: AB PT NMP GB LF FS ANA ACP GU LS WS GR. Performed the experiments: AB PT NMP LF RR BG LLB ML ADG GC ANA ACP GU LS TP GR. Analyzed the data: AB PT NMP GB LF RR BG LLB ML ADG GC FS ACP GU LS TP WS GR. Contributed reagents/materials/analysis tools: AB WS. Wrote the paper: AB PT NMP GB LF RR BG LLB ML ADG GC FS ANA TP WS GR.</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>22</day><month>2</month><year>2010</year></pub-date><volume>5</volume><issue>2</issue><elocation-id>e9348</elocation-id><history><date date-type="received"><day>15</day><month>9</month><year>2009</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2010</year></date></history><permissions><copyright-statement>Bertolino et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><sec><title>Background</title><p>Variation of the gene coding for D2 receptors (<italic>DRD2</italic>) has been associated with risk for schizophrenia and with working memory deficits. A functional intronic SNP (rs1076560) predicts relative expression of the two D2 receptors isoforms, D2S (mainly pre-synaptic) and D2L (mainly post-synaptic). However, the effect of functional genetic variation of <italic>DRD2</italic> on striatal dopamine D2 signaling and on its correlation with prefrontal activity during working memory in humans is not known.</p></sec><sec><title>Methods</title><p>Thirty-seven healthy subjects were genotyped for rs1076560 (G&#x0003e;T) and underwent SPECT with &#x0005b;<sup>123</sup>I&#x0005d;IBZM (which binds primarily to post-synaptic D2 receptors) and with &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT (which binds to pre-synaptic dopamine transporters, whose activity and density is also regulated by pre-synaptic D2 receptors), as well as BOLD fMRI during N-Back working memory.</p></sec><sec><title>Results</title><p>Subjects carrying the T allele (previously associated with reduced D2S expression) had striatal reductions of &#x0005b;<sup>123</sup>I&#x0005d;IBZM and of &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT binding. <italic>DRD2</italic> genotype also differentially predicted the correlation between striatal dopamine D2 signaling (as identified with factor analysis of the two radiotracers) and activity of the prefrontal cortex during working memory as measured with BOLD fMRI, which was positive in GG subjects and negative in GT.</p></sec><sec><title>Conclusions</title><p>Our results demonstrate that this functional SNP within <italic>DRD2</italic> predicts striatal binding of the two radiotracers to dopamine transporters and D2 receptors as well as the correlation between striatal D2 signaling with prefrontal cortex activity during performance of a working memory task. These data are consistent with the possibility that the balance of excitatory/inhibitory modulation of striatal neurons may also affect striatal outputs in relationship with prefrontal activity during working memory performance within the cortico-striatal-thalamic-cortical pathway.</p></sec></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Susceptibility to schizophrenia is explained for the largest fraction by genetic variation <xref ref-type="bibr" rid="pone.0009348-Harrison1">&#x0005b;1&#x0005d;</xref>. While the specific genes conferring risk for schizophrenia are still undetermined, several studies and meta-analyses point to the potential involvement of the gene for dopamine D2 receptors (<italic>DRD2</italic>) <xref ref-type="bibr" rid="pone.0009348-Allen1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Glatt1">&#x0005b;3&#x0005d;</xref>. Moreover, several lines of evidence suggest involvement of the dopamine system and of D2 signaling in the pathophysiology of schizophrenia <xref ref-type="bibr" rid="pone.0009348-Weinberger1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Carlsson1">&#x0005b;6&#x0005d;</xref>. Indeed, all antipsychotics available on the market block dopamine D2 receptors (even though other receptors may also be involved). Phenomenologically, schizophrenia is characterized by cognitive deficits, in particular in the working memory domain <xref ref-type="bibr" rid="pone.0009348-Weinberger1">&#x0005b;4&#x0005d;</xref>. Working memory deficits in schizophrenia have been associated with dysfunction of the prefrontal cortex <xref ref-type="bibr" rid="pone.0009348-Callicott1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Manoach1">&#x0005b;8&#x0005d;</xref> and of the dopamine system <xref ref-type="bibr" rid="pone.0009348-Weinberger1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Carlsson1">&#x0005b;6&#x0005d;</xref>. Indeed, several authors have hypothesized that altered working memory performance and related prefrontal activity can be part of a systems level pathophysiological mechanism also involving dopamine D2 receptors in the striatum <xref ref-type="bibr" rid="pone.0009348-Weinberger1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Carlsson1">&#x0005b;6&#x0005d;</xref>. The key anatomical and molecular mechanisms regulating the relationship between <italic>DRD2</italic> genetic risk, dopamine dysregulation of D2 signaling, and working memory dysfunction remain undetermined.</p><p>A large series of studies in animals indicates that prefrontal neuronal activity during performance of working memory tasks is regulated by dopamine <xref ref-type="bibr" rid="pone.0009348-Seamans1">&#x0005b;9&#x0005d;</xref>. In the prefrontal cortex both D1 and D2 receptors are involved in working memory, with the latter more specifically implicated in the response phase <xref ref-type="bibr" rid="pone.0009348-Seamans1">&#x0005b;9&#x0005d;</xref>. In this regard, genetically modified mice lacking D2 receptors exhibit behavioral working memory deficits and reduced activity of the prefrontal cortex during treatment with D1 agonists <xref ref-type="bibr" rid="pone.0009348-Glickstein1">&#x0005b;10&#x0005d;</xref>. Moreover, behavioral performance and prefrontal neuronal activity during working memory (WM) performance are also regulated by dopamine and D2 receptors in the striatum, a key node within the cortico-striatal-thalamic-cortical circuit <xref ref-type="bibr" rid="pone.0009348-OReilly1">&#x0005b;11&#x0005d;</xref>. In this regard, an experiment inducing developmental over-expression of striatal D2 receptors demonstrated specific working memory deficits and altered prefrontal activity to D1 stimulation <xref ref-type="bibr" rid="pone.0009348-Kellendonk1">&#x0005b;12&#x0005d;</xref>. These experiments in animals indicate that genetically modified striatal D2 signaling has systems-level effects in dopamine modulation of prefrontal cortical activity and related behaviors. Data in humans have been consistent with these studies demonstrating that infusion of D2 receptor agonists or antagonists is respectively associated with relative improvement or deterioration of working memory performance <xref ref-type="bibr" rid="pone.0009348-Mehta1">&#x0005b;13&#x0005d;</xref> as well as of prefrontal and striatal activity <xref ref-type="bibr" rid="pone.0009348-Kimberg1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Mehta2">&#x0005b;15&#x0005d;</xref>. Other imaging studies in humans have also demonstrated that striatal dopamine and D2 signaling are correlated with prefrontal activity or behavioral performance during different cognitive operations <xref ref-type="bibr" rid="pone.0009348-Landau1">&#x0005b;16&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Volkow1">&#x0005b;18&#x0005d;</xref>.</p><p>D2 receptors in the striatum are both pre- and post-synaptic and affect the final output of the striatum to the thalamus, providing an important regulation of prefrontal cortex stimulation <xref ref-type="bibr" rid="pone.0009348-Watanabe1">&#x0005b;19&#x0005d;</xref>. At present, however, it is unknown whether genetic determination of pre- and post-synaptic striatal D2 signaling as modulated by dopamine is a mechanism contributing to neuronal activity in prefrontal cortex in humans. The D2 receptor gene (<italic>DRD2</italic>) codes for two isoforms, D2S (short) and D2L (long). D2L receptors mainly mediate post-synaptic signaling. D2S receptors mainly serve as auto-receptors on pre-synaptic neurons <xref ref-type="bibr" rid="pone.0009348-Usiello1">&#x0005b;20&#x0005d;</xref>, even though they are also found on post-synaptic neurons <xref ref-type="bibr" rid="pone.0009348-Centonze1">&#x0005b;21&#x0005d;</xref>. Moreover, pre-synaptic D2 receptors strongly contribute to physically regulate density and activity of the dopamine transporter (DAT) <xref ref-type="bibr" rid="pone.0009348-Dickinson1">&#x0005b;22&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>. An intronic <italic>DRD2</italic> polymorphism (<italic>rs1076560</italic>, G&#x0003e;T) is associated with mRNA splicing <xref ref-type="bibr" rid="pone.0009348-Zhang1">&#x0005b;30&#x0005d;</xref>. More specifically, the minor T allele is associated with relatively reduced expression of D2S in prefrontal cortex and striatum as well as with altered activity of the striato-thalamic-prefrontal pathway during WM in healthy subjects <xref ref-type="bibr" rid="pone.0009348-Zhang1">&#x0005b;30&#x0005d;</xref> and in schizophrenia <xref ref-type="bibr" rid="pone.0009348-Bertolino2">&#x0005b;31&#x0005d;</xref>. However, the effect of this SNP on prefrontal cortical activity may be also because of indirect effects via the striatum <xref ref-type="bibr" rid="pone.0009348-OReilly1">&#x0005b;11&#x0005d;</xref>. The effects of this genetic variant on pre- and post-synaptic signaling of dopamine in the striatum are not known. In this study in healthy humans, we hypothesized that this functional <italic>DRD2</italic> variant, rs1076560, would be associated: with differential binding of &#x0005b;<sup>123</sup>I&#x0005d;IBZM measured with SPECT, which reflects availability of post-synaptic D2 receptors <xref ref-type="bibr" rid="pone.0009348-Kung1">&#x0005b;32&#x0005d;</xref>; with differential binding of &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT measured with SPECT, which reflects availability of pre-synaptic DAT <xref ref-type="bibr" rid="pone.0009348-Scheffel1">&#x0005b;33&#x0005d;</xref>; and with how a factor score of the two radiotracers identifying striatal D2 signaling would predict prefrontal activity measured with BOLD fMRI during performance of a working memory task. Moreover, in an effort to test the relative specificity of these associations, subjects were also genotyped for <italic>COMT</italic> Val<sup>158</sup>Met genotype (rs4680). COMT is a key enzyme for dopamine catabolism in prefrontal cortex but not in striatum <xref ref-type="bibr" rid="pone.0009348-Gogos1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Sesack1">&#x0005b;35&#x0005d;</xref> and this polymorphism alters activity of the enzyme in association with prefrontal function <xref ref-type="bibr" rid="pone.0009348-Egan1">&#x0005b;36&#x0005d;</xref>.</p></sec><sec id="s2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="s2a"><title>Participants to &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT SPECT, &#x0005b;<sup>123</sup>I&#x0005d;IBZM SPECT, and BOLD fMRI Studies</title><p>Thirty-seven healthy subjects (16 males, mean age&#x000b1;SD 23.5&#x000b1;3.0 years) participated to &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT SPECT. Thirty-two of these subjects underwent &#x0005b;<sup>123</sup>I&#x0005d;IBZM SPECT and twenty-eight also underwent Blood Oxygen Level Dependent (BOLD) functional Magnetic Resonance Imaging (fMRI) during performance of the N-Back task. Exclusion criteria included history of significant drug or alcohol abuse (no active drug use in the past year), head trauma with loss of consciousness, and any significant medical condition. Parental socio-economical status (Hollingshead Scale 40.4&#x000b1;14.9), handedness (Edinburgh Inventory 0.74&#x000b1;0.4), and total IQ (WAIS-R, 108.1&#x000b1;14.8) were measured. The present study was approved by the local IRB. After complete description of the study to the subjects, written informed consent was obtained.</p><sec id="s2a1"><title>Genotype determination</title><p><italic>DRD2</italic> rs1076560 genotypes were determined as in <xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Bertolino2">&#x0005b;31&#x0005d;</xref>. SNP rs1076560 was analyzed with allele-specific PCR primers as described <xref ref-type="bibr" rid="pone.0009348-Papp1">&#x0005b;37&#x0005d;</xref> or SNaPshot (Applied Biosciences (ABI), Foster City CA) <xref ref-type="bibr" rid="pone.0009348-Zhang2">&#x0005b;38&#x0005d;</xref>. Consistent with the distribution observed in earlier studies <xref ref-type="bibr" rid="pone.0009348-Zhang2">&#x0005b;38&#x0005d;</xref>, no <italic>DRD2 TT</italic> subjects were observed in this sample. <italic>COMT</italic> Val<sup>158</sup>Met genotype (rs4680) was determined as a restriction fragment length polymorphism after PCR amplification and digestion with <italic>Nla</italic>III <xref ref-type="bibr" rid="pone.0009348-Bertolino3">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino4">&#x0005b;40&#x0005d;</xref>. The allelic distribution of <italic>DRD2</italic> and <italic>COMT</italic> was in Hardy Weinberg equilibrium (<italic>DRD2</italic> df 1, chi<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;2.1, p&#x0003e;0.1, <italic>COMT</italic> df 2, chi<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;1.3, p&#x0003e;0.4).</p></sec><sec id="s2a2"><title>Acquisition of SPECT data</title><p>Each subject was injected intravenously with an average of 150 MBq (range 111&#x02013;186 MBq) of commercially available &#x0005b;<sup>123</sup>I&#x0005d; FP CIT or &#x0005b;<sup>123</sup>I&#x0005d;IBZM radiotracer (GE Healthcare, Amersham, UK) <xref ref-type="bibr" rid="pone.0009348-Catafau1">&#x0005b;41&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Meyer1">&#x0005b;43&#x0005d;</xref>. These two radiotracers bind to dopamine transporters <xref ref-type="bibr" rid="pone.0009348-Scheffel1">&#x0005b;33&#x0005d;</xref> or D2 receptors <xref ref-type="bibr" rid="pone.0009348-Kung1">&#x0005b;32&#x0005d;</xref>, respectively. Potassium Iodide solution (Lugol) was administered at least 3 hours before and 12 hours after radiopharmaceutical injection to block thyroid uptake of free radioactive iodide. Images were acquired 3&#x02013;6 h after &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT injection <xref ref-type="bibr" rid="pone.0009348-Seibyl1">&#x0005b;44&#x0005d;</xref> or 1.5 hours after &#x0005b;<sup>123</sup>I&#x0005d;IBZM injection <xref ref-type="bibr" rid="pone.0009348-Brucke1">&#x0005b;45&#x0005d;</xref>. A dual-head gamma camera (Infinia, General Electric) equipped with parallel-hole, low-energy high-resolution collimators was used. SPECT data were acquired using the following parameters: 128&#x000d7;128 matrix, rotation of 360&#x000b0;, 60 view, 6&#x000b0; view angle, 45 s for projection. Slice thickness was 3.68 mm, acquisition time was 22 minutes; total brain counts &#x0003e;1 million were achieved in all examinations. Reconstruction was performed by filtered back-projection with a Butterworth filter (cut-off frequency: 0.3 cycle/cm, 10th order) to provide transaxial slices that were attenuation corrected. Attenuation correction was performed according to Chang's method, (attenuation coefficient: 0.12 cm<sup>&#x02212;1</sup>), after manually drawing an ellipse around the head contour <xref ref-type="bibr" rid="pone.0009348-Tatsch1">&#x0005b;46&#x0005d;</xref>. System spatial resolution (full width at half-maximum) at a radius of rotation of 15.9 cm is 11 mm, as reported elsewhere <xref ref-type="bibr" rid="pone.0009348-Soret1">&#x0005b;47&#x0005d;</xref>. For analysis of striatal radiotracer uptake, slices were reoriented parallel to the canthomeatal line.</p></sec><sec id="s2a3"><title>Processing of SPECT data</title><p>The irreversible binding characteristics and the stability of regional &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT and of &#x0005b;<sup>123</sup>I&#x0005d;IBZM uptake have been shown to allow estimation of the specific-to-nondisplaceable equilibrium partition coefficient (V3&#x02033;), which is proportional to free transporter or receptor density (Bmax) <xref ref-type="bibr" rid="pone.0009348-Laruelle1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Frankle1">&#x0005b;49&#x0005d;</xref>. V3&#x02033; can be calculated as indicated earlier <xref ref-type="bibr" rid="pone.0009348-Laruelle1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Scherfler1">&#x0005b;50&#x0005d;</xref>. Under equilibrium conditions between a compartment with specific binding and a compartment representing nonspecifically bound and free activity, V3&#x02033; is proportional to Bmax given that the dissociation constant and the volume of distribution of the nonspecifically bound and free activity compartment (V2) are relatively invariant. The occipital region was selected as the background region because 1) the density of dopamine D2 and DAT proteins is negligible compared with the striatum <xref ref-type="bibr" rid="pone.0009348-Lidow1">&#x0005b;51&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Lewis1">&#x0005b;52&#x0005d;</xref>; 2) this region can be identified with greater reliability than the cerebellum <xref ref-type="bibr" rid="pone.0009348-Laruelle2">&#x0005b;53&#x0005d;</xref>; 3) in humans &#x0005b;<sup>123</sup>I&#x0005d; IBZM activity in the occipital region is equal to the nonspecific activity in the striatum <xref ref-type="bibr" rid="pone.0009348-Seibyl2">&#x0005b;54&#x0005d;</xref>. Therefore, as in earlier studies <xref ref-type="bibr" rid="pone.0009348-Laruelle2">&#x0005b;53&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Beukers1">&#x0005b;55&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Verhoeff1">&#x0005b;56&#x0005d;</xref>, the occipital region was used to model non-specifically bound and free activity compartment. V3&#x02033; can be calculated in all voxels with the formula as in <xref ref-type="bibr" rid="pone.0009348-Scherfler1">&#x0005b;50&#x0005d;</xref>:<disp-formula><graphic xlink:href="pone.0009348.e001"/></disp-formula>where VT represents specific binding, and V2 the nonspecifically bound and the free activity compartment.</p><p>Image transformation, calculation of V3&#x02033; and statistical analysis was performed using SPM5 (Wellcome Department of Cognitive Neurology, London, UK). V2 was calculated with a ROI of the occipital lobe from the WFU Pickatlas (<ext-link ext-link-type="uri" xlink:href="http://fmri.wfubmc.edu/cms/software#PickAtlas">http://fmri.wfubmc.edu/cms/software#PickAtlas</ext-link>) <xref ref-type="bibr" rid="pone.0009348-Lancaster1">&#x0005b;57&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-TzourioMazoyer1">&#x0005b;59&#x0005d;</xref>. Since parametric images of &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT and &#x0005b;<sup>123</sup>I&#x0005d;IBZM V3&#x02033; lack anatomical detail, an indirect approach was employed for spatial normalization as detailed in <xref ref-type="bibr" rid="pone.0009348-Scherfler1">&#x0005b;50&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Rakshi1">&#x0005b;60&#x0005d;</xref>. Briefly, the raw &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT and &#x0005b;<sup>123</sup>I&#x0005d;IBZM SPECT data of each subject were normalized on the SPECT template in MNI (Montreal Neurological Institute) space <xref ref-type="bibr" rid="pone.0009348-Scherfler1">&#x0005b;50&#x0005d;</xref> with a 12-parameter affine transformation of the raw data onto the template image followed by estimation of the nonlinear deformations between the applied images. A mean image of the previously normalized raw data acquisitions was then computed and used as a template image. For each individual SPECT acquisition, a parametric V3&#x02033; image was calculated. The raw data image was transformed to the template image and the resulting transformation parameters were then applied to the corresponding subject's parametric V3&#x02033; image. The spatially normalized parametric images were convolved with a gaussian kernel (6&#x000d7;6&#x000d7;6 mm) for smoothing.</p></sec><sec id="s2a4"><title>Statistical analyses of SPECT data</title><p>Two sample T tests were used within SPM5 to evaluate potential differences between genetic groups with a statistical threshold p&#x0003c;0.005, with further correction for multiple comparisons within ROIs in putamen obtained with the WFU_PickAtlas tool, p&#x0200a;&#x0003d;&#x0200a;0.05.</p><p>Binding of &#x0005b;<sup>123</sup>I&#x0005d; FP-CIT and of &#x0005b;<sup>123</sup>I&#x0005d; IBZM is associated with protein density and affinity for the radiotracer as well as with the relative concentration of endogenous dopamine occupying these proteins <xref ref-type="bibr" rid="pone.0009348-Laruelle3">&#x0005b;61&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Laruelle4">&#x0005b;62&#x0005d;</xref>. Moreover, there is an extensive literature detailing the interaction between dopamine transporters and D2 receptors <xref ref-type="bibr" rid="pone.0009348-Dickinson1">&#x0005b;22&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Jones1">&#x0005b;63&#x0005d;</xref>. Therefore, we hypothesized that the effects of <italic>DRD2</italic> genotype on striatal dopamine D2 signaling would be additive and therefore identifiable with a measure reflecting the shared and not the unique variance derived by the two radiotracer binding measures. This index derived by factor analysis would reflect individual dopamine D2 signaling and could be used for correlation with fMRI activity. Therefore, we used a factor analysis approach using a principal component analysis (PCA, total variance used) as a reduction method <xref ref-type="bibr" rid="pone.0009348-HIll1">&#x0005b;64&#x0005d;</xref> to combine binding data from the two radiotracers into a single factor. We performed a factor analysis using Principal component Analysis (PCA) with STATISTICA (StatSoft, Tulsa, Oklahoma). &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT and &#x0005b;<sup>123</sup>I&#x0005d;IBZM V3&#x02033; data were extracted in each subject from a basal ganglia ROI, which included bilateral caudate and putamen. ROIs were identified using the WFU PickAtlas software (Functional MRI Laboratory at the Wake Forest University School of Medicine, <ext-link ext-link-type="uri" xlink:href="http://www.rad.wfubmc.edu/fmri">http://www.rad.wfubmc.edu/fmri</ext-link>) <xref ref-type="bibr" rid="pone.0009348-Lancaster1">&#x0005b;57&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-TzourioMazoyer1">&#x0005b;59&#x0005d;</xref>. One principal component (PC) that is a linear combination of the two binding measures was estimated. This PC represents average dopamine D2 signaling weighted by the variance of the binding measures. For each subject we calculated a factor loading, which indicates the weight of each subject bindings in the PC. PC loadings were then used as predictors in random effects analyses to identify potential relationships with the fMRI data in SPM (see below).</p><p>&#x003c9;<sup>2</sup> is an effect size measure which estimates the proportion of variance in a dependent measure accounted for by independent categorical variables in the population from which the sample was drawn. Thus, we used &#x003c9;<sup>2</sup> to measure the amount of variance accounted for by <italic>DRD2</italic> genotype. &#x003c9;<sup>2</sup> is given by the equation: <inline-formula><inline-graphic xlink:href="pone.0009348.e002.jpg" mimetype="image"/></inline-formula>.</p></sec></sec><sec id="s2b"><title>BOLD fMRI Data Acquisition and Processing</title><sec id="s2b1"><title>N-Back working memory paradigm</title><p>During fMRI, all subjects completed a blocked paradigm of the N-Back task with a 2-Back working memory condition and a non-memory guided control condition 0-Back <xref ref-type="bibr" rid="pone.0009348-Bertolino4">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Callicott2">&#x0005b;65&#x0005d;</xref>. This paradigm has been extensively used to evaluate activity of prefrontal cortex. &#x0201c;N-back&#x0201d; refers to how far back in the sequence of stimuli the subject had to recall. The stimuli consisted of numbers (1&#x02013;4) shown in random sequence and displayed at the points of a diamond-shaped box. There was a visually paced motor task which also served as a non-memory guided control condition (0-Back) that simply required subjects to identify the stimulus currently seen. In the working memory condition, the task required recollection of a stimulus seen two stimuli (2-Back) previously while continuing to encode additionally incoming stimuli. Performance data were recorded as the number of correct responses (accuracy) and as reaction time.</p></sec><sec id="s2b2"><title>BOLD fMRI acquisition parameters</title><p>Each subject was scanned with a 3T MR scanner (GE) with a gradient-echo echo-planar imaging (EPI) sequence using the following parameters: 20 contiguous axial slices, slice thickness&#x0200a;&#x0003d;&#x0200a;5 mm, echo time&#x0200a;&#x0003d;&#x0200a;30 msec, repetition time&#x0200a;&#x0003d;&#x0200a;2000 msec; field of view 24 cm; matrix 64&#x000d7;64, voxel size after normalization&#x0200a;&#x0003d;&#x0200a;3.75 mm isotropic <xref ref-type="bibr" rid="pone.0009348-Bertolino4">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino5">&#x0005b;66&#x0005d;</xref>. We used a simple block design in which each block consisted of eight alternating 0-Back and 2-Back conditions (each lasting 30 seconds), obtained in 4 min and 8 sec, 120 whole-brain fMRI volumes. The first four scans of the time series were acquired to allow the signal to reach a steady state and were not included in the final analysis.</p></sec><sec id="s2b3"><title>BOLD-fMRI image analysis. Preprocessing and statistical analyses</title><p>Analysis of the fMRI data was completed using statistical parametric mapping (SPM5; <ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm">http://www.fil.ion.ucl.ac.uk/spm</ext-link>). Images for each subject were realigned to the first volume in the time series to correct for head motion (&#x0003c;2.5 mm of translation, &#x0003c;1.5&#x000b0; rotation), spatially normalized into a standard stereotactic space (Montreal Neurological Institute, MNI, template) using a 12 parameter affine model and smoothed to minimize noise and residual differences in gyral anatomy with a Gaussian filter, set at 10 mm full-width at half-maximum. Voxel-wise signal intensities were ratio normalized to the whole-brain global mean. Each experimental condition was modeled with a box car convolved with the hemodynamic response function (HRF) at each voxel. Predetermined condition effects at each voxel were calculated using a t-statistic, producing a statistical image for the contrasts of 2-Back versus 0-Back (N-Back). All these individual contrast images were then used in second-level random effects models at the group level. ANOVA was used to evaluate the main effects of working memory and of <italic>DRD2</italic> genotype. Then, we performed separate linear regression analyses for the two groups of subjects (GG and GT) within SPM5. First, we entered the single subject contrasts (2Back&#x0003e;0Back) with &#x0005b;<sup>123</sup>I&#x0005d; IBZM or &#x0005b;<sup>123</sup>I&#x0005d; FP-CIT binding (from the anatomical ROIs differentiating the two genotype groups) as predictors. These analyses do not exclude that the biological effects of <italic>DRD2</italic> genotype can result by additive effects of genetic variants on both pre- and post- synaptic compartments of D2 systems that would be captured by a D2 signaling factor (as detailed above). Thus, we also regressed separately for the two genotype groups the single subject contrasts (2Back&#x0003e;0Back) with factor scores from the factor analysis of the SPECT data of each individual subject as predictors. All statistical maps were thresholded at a level of <italic>p</italic>&#x0003c;0.005 uncorrected, with further FWE small volume correction for multiple comparisons with &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 using a 10 mm radius sphere centered around coordinates in prefrontal cortex published in previous studies of working memory. These coordinates included: x &#x02212;20, y 8, z 56 <xref ref-type="bibr" rid="pone.0009348-Callicott2">&#x0005b;65&#x0005d;</xref>; x &#x02212;32, y 14, z 38 <xref ref-type="bibr" rid="pone.0009348-Curtis1">&#x0005b;67&#x0005d;</xref>; x &#x02212;52, y 26, z 20 <xref ref-type="bibr" rid="pone.0009348-Tan1">&#x0005b;68&#x0005d;</xref>; x 38, y 34, z 11 <xref ref-type="bibr" rid="pone.0009348-Manoach2">&#x0005b;69&#x0005d;</xref>. The studies used to perform small volume correction of our data were selected based on the characteristics of the working memory task that we have used <xref ref-type="bibr" rid="pone.0009348-Callicott2">&#x0005b;65&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Curtis1">&#x0005b;67&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Manoach2">&#x0005b;69&#x0005d;</xref>, as well as on the aim of the present study (i.e. to investigate the impact of variability in dopamine genes on modulation of the functional activity of the prefronto-striatal network, <xref ref-type="bibr" rid="pone.0009348-Tan1">&#x0005b;68&#x0005d;</xref>). Because we did not have <italic>a priori</italic> hypotheses regarding the activity of brain regions outside of the prefrontal cortex, we used a statistical threshold of p&#x0200a;&#x0003d;&#x0200a;0.05, corrected for multiple comparisons across all voxels, for these whole-brain comparisons. For anatomical localization, statistical maxima of activation were converted to conform to the standard space of Talairach and Tournoux.</p></sec><sec id="s2b4"><title>Polynomial regression to identify the correlation between behavior, BOLD fMRI, and SPECT data</title><p>Because previous evidence supports the hypothesis that the relationship between working memory behavioral performance with dopamine signaling and prefrontal activity is non-linear <xref ref-type="bibr" rid="pone.0009348-Seamans1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Williams1">&#x0005b;70&#x0005d;</xref>, we performed polynomial regression to assess this relationship in our data. A second order (quadratic) polynomial model was fitted to the data separately in the two genotype groups: behavioral performance at 2-Back was the dependent variable; the dopamine D2 signaling factor score (see above) and BOLD fMRI activity in prefrontal cortex (from clusters correlated with the factor score itself) were the independent variables. The F-statistic was used to compare the goodness of fit of quadratic relative to linear model by comparing the ratio of partitioned variances in the two genotype groups.</p></sec></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Demographics and Working Memory Performance Results</title><p>The two genotype groups did not differ for any of the demographic measures (See also Supplemental <xref ref-type="supplementary-material" rid="pone.0009348.s001">Table S1</xref>, all p&#x0003e;0.1) or for working memory behavioral performance (&#x00025; correct responses GG&#x0200a;&#x0003d;&#x0200a;83.4&#x000b1;14.3, GT&#x0200a;&#x0003d;&#x0200a;88.1&#x000b1;15.4; Reaction Time GG&#x0200a;&#x0003d;&#x0200a;512.4&#x000b1;219.1 msec, GT&#x0200a;&#x0003d;&#x0200a;562.0&#x000b1;289.5; all p&#x0003e;0.2) thus allowing us to examine the association of genotypes with brain activity and dopamine signaling independent of behavioral variation in this sample.</p></sec><sec id="s3b"><title>SPECT Results</title><p>Two-sample t test in SPM5 demonstrated that subjects homozygous for the G allele had significantly greater specific binding of &#x0005b;<sup>123</sup>I&#x0005d;IBZM in right putamen (GG N&#x0200a;&#x0003d;&#x0200a;21, GT N&#x0200a;&#x0003d;&#x0200a;11, Z&#x0200a;&#x0003d;&#x0200a;2.68; k&#x0200a;&#x0003d;&#x0200a;7; p&#x0200a;&#x0003d;&#x0200a;0.05, corrected; x 30, y 6, z 0, <xref ref-type="fig" rid="pone-0009348-g001">Figure 1</xref>) compared with GT subjects. <italic>DRD2</italic> genotype explained 20&#x00025; of the variance in &#x0005b;<sup>123</sup>I&#x0005d;IBZM binding as indicated by &#x003c9;<sup>2</sup>. Similarly, GG subjects also had significantly greater specific binding of &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT in left putamen (GG N&#x0200a;&#x0003d;&#x0200a;26, GT N&#x0200a;&#x0003d;&#x0200a;11, Z&#x0200a;&#x0003d;&#x0200a;3.1; k&#x0200a;&#x0003d;&#x0200a;13; p&#x0200a;&#x0003d;&#x0200a;0.03, corrected; x &#x02212;30, y 9, z 18, <xref ref-type="fig" rid="pone-0009348-g002">Figure 2</xref>). <italic>DRD2</italic> genotype explained 10&#x00025; of &#x0005b;<sup>123</sup>I&#x0005d; FP-CIT binding variance.</p><fig id="pone-0009348-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009348.g001</object-id><label>Figure 1</label><caption><title>Association between <italic>DRD2 rs1076560</italic> genotype and &#x0005b;<sup>123</sup>I&#x0005d;IBZM binding.</title><p>Coronal section of the effect of <italic>DRD2 rs1076560</italic> genotype (GG&#x0003e;GT) on &#x0005b;<sup>123</sup>I&#x0005d;IBZM specific binding (V3&#x02033;) in right putamen (left) and relative scatterplot of individual data points from the cluster differentiating the two groups (right).</p></caption><graphic xlink:href="pone.0009348.g001"/></fig><fig id="pone-0009348-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009348.g002</object-id><label>Figure 2</label><caption><title>Association between <italic>DRD2 rs1076560</italic> genotype and &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT binding.</title><p>Coronal section of the effect of <italic>DRD2 rs1076560</italic> genotype (GG&#x0003e;GT) on &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT specific binding (V3&#x02033;) in left putamen (left) and relative scatterplot of individual data points from the cluster differentiating the two groups (right).</p></caption><graphic xlink:href="pone.0009348.g002"/></fig><p>Factor Analysis demonstrated that both data from &#x0005b;<sup>123</sup>I&#x0005d;IBZM and &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT basal ganglia ROIs load into one factor (GG N&#x0200a;&#x0003d;&#x0200a;21, GT N&#x0200a;&#x0003d;&#x0200a;11, Factor loading for &#x0005b;<sup>123</sup>I&#x0005d; FP-CIT&#x0200a;&#x0003d;&#x0200a;0.76, factor loading for &#x0005b;<sup>123</sup>I&#x0005d; IBZM&#x0200a;&#x0003d;&#x0200a;0.76, Eigenvalue 1.16, 58&#x00025; Total Variance) which presumably reflects dopamine D2 signaling.</p><p>In an effort to test the specificity of the association with <italic>DRD2</italic>, SPECT data were also grouped and analyzed for <italic>COMT</italic> Val<sup>158</sup>Met genotype (rs4680). Because of the small number of Met homozygous subjects, Met/Met and Met/Val subjects were grouped together. Two sample t tests in SPM5 demonstrated no significant association of <italic>COMT</italic> genotype with both &#x0005b;<sup>123</sup>I&#x0005d;IBZM (Met carriers N&#x0200a;&#x0003d;&#x0200a;19; Val/Val N&#x0200a;&#x0003d;&#x0200a;8) and &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT data (Met carriers N&#x0200a;&#x0003d;&#x0200a;20; Val/Val N&#x0200a;&#x0003d;&#x0200a;10), even after lowering the statistical threshold to p&#x0003c;0.01, uncorrected (data not shown).</p></sec><sec id="s3c"><title>fMRI Results</title><sec id="s3c1"><title>Effect of the 2-Back working memory task</title><p>As expected from previous studies with the N-Back task <xref ref-type="bibr" rid="pone.0009348-Callicott1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino2">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino3">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino4">&#x0005b;40&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Callicott2">&#x0005b;65&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino6">&#x0005b;71&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Callicott3">&#x0005b;72&#x0005d;</xref>, ANOVA within SPM5 demonstrated that performance of the 2-Back working memory condition was associated with activity in a distributed network of brain regions including the prefrontal cortex, the parietal cortex, and the striatum bilaterally. Regions that also survived correction for multiple comparisons include the left middle frontal gyrus (x &#x02212;29, y 13, z 54, BA 6/8 and 9, Z&#x0200a;&#x0003d;&#x0200a;6.79, k&#x0200a;&#x0003d;&#x0200a;159, corrected p&#x0200a;&#x0003d;&#x0200a;0.000), the left inferior frontal gyrus (x &#x02212;51, y 15, z 19, BA 44/45, Z&#x0200a;&#x0003d;&#x0200a;5.55, k&#x0200a;&#x0003d;&#x0200a;83, p&#x0200a;&#x0003d;&#x0200a;0.000) and the right middle frontal gyrus (x 40, y 40, z 15, BA 10/46, Z&#x0200a;&#x0003d;&#x0200a;5.42, k&#x0200a;&#x0003d;&#x0200a;66, p&#x0200a;&#x0003d;&#x0200a;0.000).</p></sec><sec id="s3c2"><title>Effect of <italic>DRD2</italic> genotype</title><p>Consistent with earlier studies <xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Bertolino2">&#x0005b;31&#x0005d;</xref>, ANOVA within SPM5 indicated that, despite similar behavioral performance, GT subjects tend to have greater activity in prefrontal cortex (x 33, y &#x02212;1, z 45, middle frontal gyrus, BA 6, Z&#x0200a;&#x0003d;&#x0200a;3.13, k&#x0200a;&#x0003d;&#x0200a;41, p&#x0200a;&#x0003d;&#x0200a;0.001; x 63, y 8, z 7, inferior frontal gyrus, BA 44, Z&#x0200a;&#x0003d;&#x0200a;3.36, k&#x0200a;&#x0003d;&#x0200a;16, p&#x0200a;&#x0003d;&#x0200a;0.0001) and anterior cingulate (x 10, y 16, z 40, anterior cingulate, BA 32, Z&#x0200a;&#x0003d;&#x0200a;3.27, k&#x0200a;&#x0003d;&#x0200a;21, p&#x0200a;&#x0003d;&#x0200a;0.001) compared with GG subjects. However, none of these results survived correction for multiple comparisons.</p></sec><sec id="s3c3"><title>Relationship between fMRI and SPECT data</title><p>Regression analyses in SPM5 demonstrated a direct correlation between &#x0005b;<sup>123</sup>I&#x0005d; IBZM binding in right putamen with prefrontal cortex in GG subjects (x &#x02212;38, y 10, z 37, k&#x0200a;&#x0003d;&#x0200a;3, Z&#x0200a;&#x0003d;&#x0200a;3.1, p&#x0200a;&#x0003d;&#x0200a;0.02, corrected) and a negative correlation in GT subjects (x &#x02212;60, y 26, z 16, k&#x0200a;&#x0003d;&#x0200a;12, Z&#x0200a;&#x0003d;&#x0200a;3.1, p&#x0200a;&#x0003d;&#x0200a;0.05, corrected). However, no correlation was found in either group between &#x0005b;I<sup>123</sup>&#x0005d; FP CIT binding and BOLD activity during performance of the N-Back working memory task. Also, <bold>r</bold>egression analyses in SPM5 demonstrated a positive relationship between the factor score obtained from SPECT data and BOLD activity in prefrontal cortex in GG subjects (N&#x0200a;&#x0003d;&#x0200a;18; x &#x02212;26, y 10, z 54, BA 6, Z&#x0200a;&#x0003d;&#x0200a;3.6, k&#x0200a;&#x0003d;&#x0200a;5, p&#x0200a;&#x0003d;&#x0200a;0.007 corrected; BA 9 x &#x02212;34, y 16, z 30; Z&#x0200a;&#x0003d;&#x0200a;2.98, k&#x0200a;&#x0003d;&#x0200a;8, p&#x0200a;&#x0003d;&#x0200a;0.03, corrected, <xref ref-type="fig" rid="pone-0009348-g003">Figure 3</xref>)) and a negative one in GT subjects (N&#x0200a;&#x0003d;&#x0200a;10; BA 46, Z&#x0200a;&#x0003d;&#x0200a;3.36, k&#x0200a;&#x0003d;&#x0200a;12, p&#x0200a;&#x0003d;&#x0200a;0.03, corrected, x &#x02212;59, y 30, z 12; BA 46 Z&#x0200a;&#x0003d;&#x0200a;2.77, k&#x0200a;&#x0003d;&#x0200a;5, p&#x0200a;&#x0003d;&#x0200a;0.09, corrected, x 37, y 34, z 16, <xref ref-type="fig" rid="pone-0009348-g004">Figure 4</xref>; see also Supplemental <xref ref-type="supplementary-material" rid="pone.0009348.s002">Table S2</xref> for further results).</p><fig id="pone-0009348-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009348.g003</object-id><label>Figure 3</label><caption><title>Correlation between BOLD fMRI activity in prefrontal cortex and the striatal dopamine D2 signaling factor in GG subjects.</title><p>3D rendering of the correlation between the striatal dopamine D2 signaling factor and BOLD fMRI activity during the 2-Back WM task in GG subjects (left) with the relative scatterplot of the correlation in prefrontal cortex showing individual data points (right).</p></caption><graphic xlink:href="pone.0009348.g003"/></fig><fig id="pone-0009348-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009348.g004</object-id><label>Figure 4</label><caption><title>Correlation between BOLD fMRI activity in prefrontal cortex and the striatal dopamine D2 signaling factor in GT subjects.</title><p>3D rendering of the correlation between the striatal dopamine D2 signaling factor and BOLD fMRI activity during the 2-Back WM task in GT subjects (left) with the relative scatterplot of the correlation in prefrontal cortex showing individual data points (right).</p></caption><graphic xlink:href="pone.0009348.g004"/></fig><p>In GG subjects, there was a strong statistical trend for a quadratic relationship between 2-Back percent correct responses with the striatal dopamine D2 signaling factor score and prefrontal activity during working memory as measured with fMRI (R<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.45, F&#x0200a;&#x0003d;&#x0200a;2.67, df&#x0200a;&#x0003d;&#x0200a;4,13, p&#x0200a;&#x0003d;&#x0200a;0.07; F-statistic for quadratic vs. linear model (4,13)&#x0200a;&#x0003d;&#x0200a;6.44, p&#x0200a;&#x0003d;&#x0200a;0.004; Univariate Results: factor score<sup>2</sup> t&#x0200a;&#x0003d;&#x0200a;2.5, p&#x0200a;&#x0003d;&#x0200a;0.02; BOLD activity in BA9 x &#x02212;34, y 16, z 30<sup>2</sup> t&#x0200a;&#x0003d;&#x0200a;1.9, p&#x0200a;&#x0003d;&#x0200a;0.07, <xref ref-type="supplementary-material" rid="pone.0009348.s003">Figures S1</xref> and <xref ref-type="supplementary-material" rid="pone.0009348.s004">S2</xref>). In GT subjects, no such relationship was evident (R<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.22, F&#x0200a;&#x0003d;&#x0200a;0.3, df&#x0200a;&#x0003d;&#x0200a;4,5, p&#x0200a;&#x0003d;&#x0200a;0.8).</p></sec></sec></sec><sec id="s4"><title>Discussion</title><p>The results of the present study with multimodal imaging in humans demonstrate that <italic>DRD2</italic> rs1076560 genotype predicts striatal &#x0005b;<sup>123</sup>I&#x0005d;IBZM and &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT binding and the direction of the correlation between a factor score reflecting striatal D2 signaling with prefrontal activity during performance of working memory. More specifically, carriers of the T allele of rs1076560, known to be associated with relatively reduced D2S, had reduced &#x0005b;<sup>123</sup>I&#x0005d;IBZM and &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT binding. Consistent with its anatomical distribution, with a relatively specific effect of the <italic>DRD2</italic> genotype and with an earlier study which was published while the present paper was being reviewed <xref ref-type="bibr" rid="pone.0009348-Hirvonen1">&#x0005b;73&#x0005d;</xref>, <italic>COMT</italic> rs4680 genotype did not demonstrate any association with SPECT data. Importantly, the present data also indicate that <italic>DRD2</italic> genotype is associated with qualitatively different relationships between &#x0005b;<sup>123</sup>I&#x0005d;IBZM binding and the striatal factor score <bold>with</bold> prefrontal activity during working memory. GG subjects have a positive correlation which is also weakly predictive of behavioral performance, whereas in GT subjects the correlation is negative. Earlier studies from our group had provided <italic>in vitro</italic>, <italic>post mortem</italic> and <italic>in vivo</italic> evidence for the functionality of this SNP and for its association with activity of the working memory network <xref ref-type="bibr" rid="pone.0009348-Zhang1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino2">&#x0005b;31&#x0005d;</xref>. In the present study we provide evidence for a systems level genetically determined mechanism correlating striatal D2 signaling with alteration of prefrontal activity during working memory.</p><p>Even though the specificity for the two D2 isoforms is not known, &#x0005b;<sup>123</sup>I&#x0005d;IBZM is believed to bind to post-synaptic D2 receptors <xref ref-type="bibr" rid="pone.0009348-Nyberg1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Kung1">&#x0005b;32&#x0005d;</xref>. &#x0005b;<sup>123</sup>I&#x0005d;IBZM binding can be modulated by endogenous dopamine and by receptor density, affinity, and internalization <xref ref-type="bibr" rid="pone.0009348-Laruelle2">&#x0005b;53&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-AbiDargham1">&#x0005b;74&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Guo1">&#x0005b;75&#x0005d;</xref>. The <italic>rs1076560</italic> G allele has been associated with greater D2S expression, but not with total density of D2 receptors <xref ref-type="bibr" rid="pone.0009348-Zhang1">&#x0005b;30&#x0005d;</xref>. Thus, reduced &#x0005b;<sup>123</sup>I&#x0005d;IBZM binding in GT subjects can reflect reduced D2S receptors, which are also found post-synaptically <xref ref-type="bibr" rid="pone.0009348-Centonze1">&#x0005b;21&#x0005d;</xref>. Our &#x0005b;<sup>123</sup>I&#x0005d;-IBZM results are also consistent with earlier studies investigating the association between <italic>DRD2</italic> polymorphisms and D2 binding with different radiotracers <xref ref-type="bibr" rid="pone.0009348-Jonsson1">&#x0005b;76&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Ritchie1">&#x0005b;78&#x0005d;</xref>. These polymorphisms are in high linkage disequilibrium with rs1076560 and these earlier studies have reported an average 30&#x00025; reduction in D2 binding based on genotype. Our data indicate that GT subjects have an average 34&#x00025; reduction in &#x0005b;<sup>123</sup>I&#x0005d;-IBZM binding compared with GG subjects. Resting state &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT measures pre-synaptic binding to DATs <xref ref-type="bibr" rid="pone.0009348-Scheffel1">&#x0005b;33&#x0005d;</xref>. Given the robust literature providing indication of the physical and functional relationship between DATs and pre-synaptic D2 receptors <xref ref-type="bibr" rid="pone.0009348-Bolan1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>, reduced &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT binding in GT subjects may be because of reduced pre-synaptic D2S. An alternative interpretation of both SPECT datasets is also possible. Because GT subjects have reduced pre-synaptic D2S which inhibits dopamine release <xref ref-type="bibr" rid="pone.0009348-Watanabe1">&#x0005b;19&#x0005d;</xref>, reduced &#x0005b;<sup>123</sup>I&#x0005d;IBZM and &#x0005b;<sup>123</sup>I&#x0005d;FP-CIT binding may be because of greater steady-state levels of dopamine competing with the radiotracer. Consistent with these contentions and with knowledge that the main factor contributing to a relationship between pre-synaptic DATs and post-synaptic D2 receptors is dopamine itself, factor analysis of both SPECT datasets identified a factor that may reflect dopamine D2 signaling (the major element in common likely affecting binding of the two radiotracers).</p><p><italic>DRD2 rs1076560</italic> genotype was also differentially associated with the correlation between putative striatal dopamine D2 signaling (as identified with the factor score) and prefrontal activity during working memory, which was positive in GG and negative in GT subjects. A plausible cellular mechanism for these effects is the differential contribution of dopamine D2S and D2L receptors in modulation of glutamate and GABA transmission on striatal output. Both D2 isoforms participate in pre-synaptic inhibition of striatal GABA transmission, while D2S is preferentially involved in modulation of glutamate release <xref ref-type="bibr" rid="pone.0009348-Centonze1">&#x0005b;21&#x0005d;</xref>. Therefore, modulation of excitatory and inhibitory transmission in the striatum is tightly linked to balance of the two isoforms <xref ref-type="bibr" rid="pone.0009348-Centonze1">&#x0005b;21&#x0005d;</xref>. In fact, GABA spiny neurons, which account for the large majority of neuronal populations in striatum, only fire action potentials when depolarized by glutamate released by afferents from the cortex <xref ref-type="bibr" rid="pone.0009348-Calabresi1">&#x0005b;79&#x0005d;</xref>. Since <italic>DRD2 rs1076560</italic> genotype alters the relative expression of the two isoforms, our data are consistent with the possibility that the balance of excitatory/inhibitory modulation of striatal neurons may also affect striatal outputs and the relationship with prefrontal activity during working memory.</p><p>Since the present study is in healthy subjects, no direct conclusion can be drawn about schizophrenia. However, some speculations as to the relevance of the present findings to schizophrenia can be discussed. A long debated issue in the pathophysiology of schizophrenia is whether subcortical dopamine dysregulation is a primary phenomenon or rather it is associated with prefrontal cortical dysfunction <xref ref-type="bibr" rid="pone.0009348-Weinberger1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Bertolino7">&#x0005b;80&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-MeyerLindenberg1">&#x0005b;82&#x0005d;</xref>. Indeed, heritability of both these phenotypes has been demonstrated <xref ref-type="bibr" rid="pone.0009348-Huttunen1">&#x0005b;83&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Seidman1">&#x0005b;87&#x0005d;</xref>. Several studies and meta-analyses point to potential involvement of <italic>DRD2</italic> in susceptibility to schizophrenia. Genome-wide linkage meta-analyses have pointed to involvement of 11q <xref ref-type="bibr" rid="pone.0009348-Lewis2">&#x0005b;88&#x0005d;</xref>. Metanalyses of case-control studies indicate SNPs rs1801028 (Cys<sup>311</sup>Ser), rs2283265, and rs6277 (C<sup>957</sup>T) <xref ref-type="bibr" rid="pone.0009348-Allen1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Glatt1">&#x0005b;3&#x0005d;</xref> as implicated in risk for schizophrenia. Other recent family-based and case control studies have also implicated these SNPs <xref ref-type="bibr" rid="pone.0009348-Betcheva1">&#x0005b;89&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Glatt2">&#x0005b;90&#x0005d;</xref>. All these SNPs are linked with rs1076560 in various degrees of LD. Given these earlier studies in the literature and the present findings, it is possible to speculate that risk for schizophrenia may involve the effects of rs1076560 on striatal dopamine signaling and its relationship with prefrontal activity. This speculation is also consistent with the above cited animal studies indicating that developmentally regulated over-expression of striatal D2 receptors is associated with behavioral working memory deficits and with altered activity of the prefrontal cortex <xref ref-type="bibr" rid="pone.0009348-Kellendonk1">&#x0005b;12&#x0005d;</xref>.</p><p>A limitation of the present study needs to be addressed. The time interval between the two SPECT scans was two weeks. Although it would have been preferable that the SPECT and fMRI scans were performed closely in time, this was not always the case and the time interval between the two SPECT scans and the fMRI scan was variable. On average, 25.6&#x000b1;3.6 months elapsed between these scans. Earlier studies have demonstrated good reproducibility for &#x0005b;<sup>123</sup>I&#x0005d; IBZM (as good as 6.5&#x000b1;5.2 <xref ref-type="bibr" rid="pone.0009348-Catafau2">&#x0005b;91&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Kegeles1">&#x0005b;92&#x0005d;</xref> and for &#x0005b;<sup>123</sup>I&#x0005d; FP CIT (5.53&#x000b1;4.12&#x00025;/0.89, <xref ref-type="bibr" rid="pone.0009348-Tsuchida1">&#x0005b;93&#x0005d;</xref>). As for fMRI, reproducibility has been investigated in several studies using different working memory paradigms. Studies have reported good reproducibility of Dorsolateral Prefrontal cortex activation in healthy subjects (Intra Class Correlation (ICC&#x0200a;&#x0003d;&#x0200a;0.81) coefficient <xref ref-type="bibr" rid="pone.0009348-Manoach3">&#x0005b;94&#x0005d;</xref>). Similar results have also been reported by other investigators <xref ref-type="bibr" rid="pone.0009348-Caceres1">&#x0005b;95&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009348-Wei1">&#x0005b;96&#x0005d;</xref>. These earlier studies suggest that it is less likely that the time interval between scans has significantly influenced the results. Moreover, it is important to underline that the relationships identified in this study reflect known neurobiological pathways. Also, there was no statistically significant difference between the two genotype groups in time elapsed between SPECT scans and fMRI (t&#x0200a;&#x0003d;&#x0200a;0.09, p&#x0200a;&#x0003d;&#x0200a;0.9) which may have unduly influenced the differential correlations. Finally, SPECT and PET studies of DAT and of D2 receptors have demonstrated between 3 and 7&#x00025; decrease of radiotracer binding per decade, especially after 40 years of age <xref ref-type="bibr" rid="pone.0009348-Ishikawa1">&#x0005b;97&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Volkow3">&#x0005b;101&#x0005d;</xref>. Since our healthy subjects are definitely younger than 40 (mean age&#x000b1;SD 23.5&#x000b1;3.0), we believe physiological dopamine signaling decline did not significantly affect our analyses over the time interval of the study. Thus, we interpret these findings as being consistent with stability of fMRI and SPECT measures and as suggesting that they reflect neurobiological mechanisms.</p><p>Another point that needs some discussion is that, at the chosen statistical threshold corrected for multiple comparisons, we failed to find a main effect of rs1076560 genotype on prefrontal activity during performance of working memory in the present dataset. In three earlier studies, we had already demonstrated association of rs1076560 with prefrontal activity during performance of the N-Back working memory task in healthy subjects with sample sizes as large as N&#x0200a;&#x0003d;&#x0200a;142 <xref ref-type="bibr" rid="pone.0009348-Bertolino1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009348-Bertolino2">&#x0005b;31&#x0005d;</xref>. In the present study, the sample included 28 healthy subjects. Despite the smaller sample size, GT subjects had greater activity in prefrontal cortex and anterior cingulate before correction for multiple comparisons. Earlier studies have demonstrated that larger sample sizes are generally needed for imaging genetics studies using corrected statistical thresholds <xref ref-type="bibr" rid="pone.0009348-MeyerLindenberg2">&#x0005b;102&#x0005d;</xref>. Therefore, the present results suggest that the lack of a statistically significant main effect of rs1076560 is likely associated with the relatively small sample size of the present fMRI study. Moreover, the main objective of the present fMRI data was to evaluate statistically significant <italic>DRD2</italic> modulation of the relationship between striatal dopamine D2 signaling with prefrontal activity during performance of working memory which should not be affected by the corrected significance of the above mentioned <italic>DRD2</italic> effect.</p><p>Our data are consistent with earlier studies about genetic effects on modulation of the relationship between mesencephalic dopamine and prefrontal cortex activity <xref ref-type="bibr" rid="pone.0009348-MeyerLindenberg3">&#x0005b;103&#x0005d;</xref>. Indeed, the ventral tegmental area in the mesencephalon may be implicated in these mechanisms. Our data also provide evidence for a genetic signature that affects striatal dopamine D2 receptor signaling and its relationship with WM prefrontal activity, a mechanism potentially involved in schizophrenia and other different brain disorders <xref ref-type="bibr" rid="pone.0009348-Weinberger1">&#x0005b;4&#x0005d;</xref>.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0009348.s001"><label>Table S1</label><caption><p>Demographics of all subjects included in the study divided by rs1076560 genotype.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0009348.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0009348.s002"><label>Table S2</label><caption><p>Results from the correlation between 2-Back WM activity and the basal ganglia SPECT factor score that were not corrected for multiple comparisons. No clusters survived the statistical threshold in the inverse correlations.</p><p>(0.04 MB DOC)</p></caption><media xlink:href="pone.0009348.s002.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0009348.s003"><label>Figure S1</label><caption><p>Relationship between behavioral performance and dopamine D2 signaling. Scatterplot of the non-linear relationship in GG subjects between working memory behavioral performance and the factor score extracted from both SPECT data sets in striatum.</p><p>(0.51 MB TIF)</p></caption><media xlink:href="pone.0009348.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0009348.s004"><label>Figure S2</label><caption><p>Relationship between behavioral performance and prefrontal activity. Scatterplot of the non-linear relationship in GG subjects between working memory behavioral performance and prefrontal activity during working memory as measured with BOLD fMRI.</p><p>(0.50 MB TIF)</p></caption><media xlink:href="pone.0009348.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to acknowledge Riccarda Lomuscio, BA, Rita Masellis, PhD, and Francesco Roselli, MD, for help with data acquisition and design of the experiment.</p></ack><ref-list><title>References</title><ref id="pone.0009348-Harrison1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>PJ</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><year>2005</year><article-title>Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.</article-title><source>Mol Psychiatry</source><volume>10</volume><fpage>40</fpage><lpage>68; image 45</lpage><pub-id pub-id-type="pmid">15263907</pub-id></mixed-citation></ref><ref id="pone.0009348-Allen1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>NC</given-names></name><name><surname>Bagade</surname><given-names>S</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Ioannidis</surname><given-names>JP</given-names></name><name><surname>Kavvoura</surname><given-names>FK</given-names></name><etal/></person-group><year>2008</year><article-title>Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.</article-title><source>Nat Genet</source><volume>40</volume><fpage>827</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">18583979</pub-id></mixed-citation></ref><ref id="pone.0009348-Glatt1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Tsuang</surname><given-names>MT</given-names></name></person-group><year>2003</year><article-title>Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia.</article-title><source>Mol Psychiatry</source><volume>8</volume><fpage>911</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">14593428</pub-id></mixed-citation></ref><ref id="pone.0009348-Weinberger1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><year>1987</year><article-title>Implications of normal brain development for the pathogenesis of schizophrenia.</article-title><source>Arch Gen Psychiatry</source><volume>44</volume><fpage>660</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">3606332</pub-id></mixed-citation></ref><ref id="pone.0009348-Kapur1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname><given-names>S</given-names></name></person-group><year>2003</year><article-title>Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.</article-title><source>Am J Psychiatry</source><volume>160</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">12505794</pub-id></mixed-citation></ref><ref id="pone.0009348-Carlsson1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>A</given-names></name><name><surname>Carlsson</surname><given-names>ML</given-names></name></person-group><year>2006</year><article-title>A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.</article-title><source>Dialogues Clin Neurosci</source><volume>8</volume><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">16640125</pub-id></mixed-citation></ref><ref id="pone.0009348-Callicott1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Verchinski</surname><given-names>BA</given-names></name><name><surname>Marenco</surname><given-names>S</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><etal/></person-group><year>2003</year><article-title>Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down.</article-title><source>Am J Psychiatry</source><volume>160</volume><fpage>2209</fpage><lpage>2215</lpage><pub-id pub-id-type="pmid">14638592</pub-id></mixed-citation></ref><ref id="pone.0009348-Manoach1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoach</surname><given-names>DS</given-names></name></person-group><year>2003</year><article-title>Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings.</article-title><source>Schizophr Res</source><volume>60</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">12591590</pub-id></mixed-citation></ref><ref id="pone.0009348-Seamans1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seamans</surname><given-names>JK</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name></person-group><year>2004</year><article-title>The principal features and mechanisms of dopamine modulation in the prefrontal cortex.</article-title><source>Prog Neurobiol</source><volume>74</volume><fpage>1</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">15381316</pub-id></mixed-citation></ref><ref id="pone.0009348-Glickstein1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glickstein</surname><given-names>SB</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Schmauss</surname><given-names>C</given-names></name></person-group><year>2002</year><article-title>Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits.</article-title><source>J Neurosci</source><volume>22</volume><fpage>5619</fpage><lpage>5629</lpage><pub-id pub-id-type="pmid">12097513</pub-id></mixed-citation></ref><ref id="pone.0009348-OReilly1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Reilly</surname><given-names>RC</given-names></name></person-group><year>2006</year><article-title>Biologically Based Computational Models of High-Level Cognition.</article-title><source>Science &#x00025;R 101126/science1127242</source><volume>314</volume><fpage>91</fpage><lpage>94</lpage></mixed-citation></ref><ref id="pone.0009348-Kellendonk1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellendonk</surname><given-names>C</given-names></name><name><surname>Simpson</surname><given-names>EH</given-names></name><name><surname>Polan</surname><given-names>HJ</given-names></name><name><surname>Malleret</surname><given-names>G</given-names></name><name><surname>Vronskaya</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.</article-title><source>Neuron</source><volume>49</volume><fpage>603</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">16476668</pub-id></mixed-citation></ref><ref id="pone.0009348-Mehta1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>MA</given-names></name><name><surname>Manes</surname><given-names>FF</given-names></name><name><surname>Magnolfi</surname><given-names>G</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><year>2004</year><article-title>Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers.</article-title><source>Psychopharmacology (Berl)</source><volume>176</volume><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">15114435</pub-id></mixed-citation></ref><ref id="pone.0009348-Kimberg1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimberg</surname><given-names>DY</given-names></name><name><surname>Aguirre</surname><given-names>GK</given-names></name><name><surname>Lease</surname><given-names>J</given-names></name><name><surname>D'Esposito</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI.</article-title><source>Hum Brain Mapp</source><volume>12</volume><fpage>246</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">11241875</pub-id></mixed-citation></ref><ref id="pone.0009348-Mehta2"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>MA</given-names></name><name><surname>McGowan</surname><given-names>SW</given-names></name><name><surname>Lawrence</surname><given-names>AD</given-names></name><name><surname>Aitken</surname><given-names>MR</given-names></name><name><surname>Montgomery</surname><given-names>AJ</given-names></name><etal/></person-group><year>2003</year><article-title>Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning.</article-title><source>Neuroimage</source><volume>20</volume><fpage>1982</fpage><lpage>1994</lpage><pub-id pub-id-type="pmid">14683704</pub-id></mixed-citation></ref><ref id="pone.0009348-Landau1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landau</surname><given-names>SM</given-names></name><name><surname>Lal</surname><given-names>R</given-names></name><name><surname>O'Neil</surname><given-names>JP</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name></person-group><year>2009</year><article-title>Striatal dopamine and working memory.</article-title><source>Cereb Cortex</source><volume>19</volume><fpage>445</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">18550595</pub-id></mixed-citation></ref><ref id="pone.0009348-Nyberg1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyberg</surname><given-names>L</given-names></name><name><surname>Andersson</surname><given-names>M</given-names></name><name><surname>Forsgren</surname><given-names>L</given-names></name><name><surname>Jakobsson-Mo</surname><given-names>S</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><etal/></person-group><year>2009</year><article-title>Striatal dopamine D2 binding is related to frontal BOLD response during updating of long-term memory representations.</article-title><source>Neuroimage</source><volume>46</volume><fpage>1194</fpage><lpage>1199</lpage><pub-id pub-id-type="pmid">19327403</pub-id></mixed-citation></ref><ref id="pone.0009348-Volkow1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>ND</given-names></name><name><surname>Gur</surname><given-names>RC</given-names></name><name><surname>Wang</surname><given-names>GJ</given-names></name><name><surname>Fowler</surname><given-names>JS</given-names></name><name><surname>Moberg</surname><given-names>PJ</given-names></name><etal/></person-group><year>1998</year><article-title>Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.</article-title><source>Am J Psychiatry</source><volume>155</volume><fpage>344</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">9501743</pub-id></mixed-citation></ref><ref id="pone.0009348-Watanabe1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Kita</surname><given-names>T</given-names></name><name><surname>Kita</surname><given-names>H</given-names></name></person-group><year>2009</year><article-title>Presynaptic actions of D2-like receptors in the rat cortico-striato-globus pallidus disynaptic connection in vitro.</article-title><source>J Neurophysiol</source><volume>101</volume><fpage>665</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">19073810</pub-id></mixed-citation></ref><ref id="pone.0009348-Usiello1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usiello</surname><given-names>A</given-names></name><name><surname>Baik</surname><given-names>JH</given-names></name><name><surname>Rouge-Pont</surname><given-names>F</given-names></name><name><surname>Picetti</surname><given-names>R</given-names></name><name><surname>Dierich</surname><given-names>A</given-names></name><etal/></person-group><year>2000</year><article-title>Distinct functions of the two isoforms of dopamine D2 receptors.</article-title><source>Nature</source><volume>408</volume><fpage>199</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">11089973</pub-id></mixed-citation></ref><ref id="pone.0009348-Centonze1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centonze</surname><given-names>D</given-names></name><name><surname>Gubellini</surname><given-names>P</given-names></name><name><surname>Usiello</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>S</given-names></name><name><surname>Tscherter</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.</article-title><source>Neuroscience</source><volume>129</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">15489038</pub-id></mixed-citation></ref><ref id="pone.0009348-Dickinson1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>SD</given-names></name><name><surname>Sabeti</surname><given-names>J</given-names></name><name><surname>Larson</surname><given-names>GA</given-names></name><name><surname>Giardina</surname><given-names>K</given-names></name><name><surname>Rubinstein</surname><given-names>M</given-names></name><etal/></person-group><year>1999</year><article-title>Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.</article-title><source>J Neurochem</source><volume>72</volume><fpage>148</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">9886065</pub-id></mixed-citation></ref><ref id="pone.0009348-Kimmel1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname><given-names>HL</given-names></name><name><surname>Joyce</surname><given-names>AR</given-names></name><name><surname>Carroll</surname><given-names>FI</given-names></name><name><surname>Kuhar</surname><given-names>MJ</given-names></name></person-group><year>2001</year><article-title>Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.</article-title><source>J Pharmacol Exp Ther</source><volume>298</volume><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">11408534</pub-id></mixed-citation></ref><ref id="pone.0009348-Lee1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>FJ</given-names></name><name><surname>Pei</surname><given-names>L</given-names></name><name><surname>Moszczynska</surname><given-names>A</given-names></name><name><surname>Vukusic</surname><given-names>B</given-names></name><name><surname>Fletcher</surname><given-names>PJ</given-names></name><etal/></person-group><year>2007</year><article-title>Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.</article-title><source>Embo J</source><volume>26</volume><fpage>2127</fpage><lpage>2136</lpage><pub-id pub-id-type="pmid">17380124</pub-id></mixed-citation></ref><ref id="pone.0009348-Meiergerd1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meiergerd</surname><given-names>SM</given-names></name><name><surname>Patterson</surname><given-names>TA</given-names></name><name><surname>Schenk</surname><given-names>JO</given-names></name></person-group><year>1993</year><article-title>D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.</article-title><source>J Neurochem</source><volume>61</volume><fpage>764</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">8336153</pub-id></mixed-citation></ref><ref id="pone.0009348-Mortensen1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortensen</surname><given-names>OV</given-names></name><name><surname>Amara</surname><given-names>SG</given-names></name></person-group><year>2003</year><article-title>Dynamic regulation of the dopamine transporter.</article-title><source>Eur J Pharmacol</source><volume>479</volume><fpage>159</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">14612147</pub-id></mixed-citation></ref><ref id="pone.0009348-Parsons1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>LH</given-names></name><name><surname>Schad</surname><given-names>CA</given-names></name><name><surname>Justice</surname><given-names>JB</given-names><suffix>Jr</suffix></name></person-group><year>1993</year><article-title>Co-adminis0tration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine.</article-title><source>J Neurochem</source><volume>60</volume><fpage>376</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">8417161</pub-id></mixed-citation></ref><ref id="pone.0009348-Bolan1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolan</surname><given-names>EA</given-names></name><name><surname>Kivell</surname><given-names>B</given-names></name><name><surname>Jaligam</surname><given-names>V</given-names></name><name><surname>Oz</surname><given-names>M</given-names></name><name><surname>Jayanthi</surname><given-names>LD</given-names></name><etal/></person-group><year>2007</year><article-title>D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.</article-title><source>Mol Pharmacol</source><volume>71</volume><fpage>1222</fpage><lpage>1232</lpage><pub-id pub-id-type="pmid">17267664</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Fazio</surname><given-names>L</given-names></name><name><surname>Di Giorgio</surname><given-names>A</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>Romano</surname><given-names>R</given-names></name><etal/></person-group><year>2009</year><article-title>Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.</article-title><source>J Neurosci</source><volume>29</volume><fpage>1224</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">19176830</pub-id></mixed-citation></ref><ref id="pone.0009348-Zhang1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Fazio</surname><given-names>L</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>Rampino</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>20552</fpage><lpage>20557</lpage><pub-id pub-id-type="pmid">18077373</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino2"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Fazio</surname><given-names>L</given-names></name><name><surname>Caforio</surname><given-names>G</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>Rampino</surname><given-names>A</given-names></name><etal/></person-group><year>2009</year><article-title>Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.</article-title><source>Brain</source><volume>132</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">18829695</pub-id></mixed-citation></ref><ref id="pone.0009348-Kung1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>HF</given-names></name><name><surname>Alavi</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Kung</surname><given-names>MP</given-names></name><name><surname>Keyes</surname><given-names>JW</given-names><suffix>Jr</suffix></name><etal/></person-group><year>1990</year><article-title>In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.</article-title><source>J Nucl Med</source><volume>31</volume><fpage>573</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">2140408</pub-id></mixed-citation></ref><ref id="pone.0009348-Scheffel1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheffel</surname><given-names>U</given-names></name><name><surname>Lever</surname><given-names>JR</given-names></name><name><surname>Abraham</surname><given-names>P</given-names></name><name><surname>Parham</surname><given-names>KR</given-names></name><name><surname>Mathews</surname><given-names>WB</given-names></name><etal/></person-group><year>1997</year><article-title>N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter.</article-title><source>Synapse</source><volume>25</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">9097393</pub-id></mixed-citation></ref><ref id="pone.0009348-Gogos1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogos</surname><given-names>JA</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Luine</surname><given-names>V</given-names></name><name><surname>Santha</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.</article-title><source>Proc Natl Acad Sci U S A</source><volume>95</volume><fpage>9991</fpage><lpage>9996</lpage><pub-id pub-id-type="pmid">9707588</pub-id></mixed-citation></ref><ref id="pone.0009348-Sesack1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Hawrylak</surname><given-names>VA</given-names></name><name><surname>Guido</surname><given-names>MA</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name></person-group><year>1998</year><article-title>Cellular and subcellular localization of the dopamine transporter in rat cortex.</article-title><source>Adv Pharmacol</source><volume>42</volume><fpage>171</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">9327871</pub-id></mixed-citation></ref><ref id="pone.0009348-Egan1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Kolachana</surname><given-names>BS</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mazzanti</surname><given-names>CM</given-names></name><etal/></person-group><year>2001</year><article-title>Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>6917</fpage><lpage>6922</lpage><pub-id pub-id-type="pmid">11381111</pub-id></mixed-citation></ref><ref id="pone.0009348-Papp1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papp</surname><given-names>AC</given-names></name><name><surname>Pinsonneault</surname><given-names>JK</given-names></name><name><surname>Cooke</surname><given-names>G</given-names></name><name><surname>Sadee</surname><given-names>W</given-names></name></person-group><year>2003</year><article-title>Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves.</article-title><source>Bio Techniques</source><volume>34</volume><fpage>1067</fpage><lpage>1072</lpage></mixed-citation></ref><ref id="pone.0009348-Zhang2"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Papp</surname><given-names>AC</given-names></name><name><surname>Sadee</surname><given-names>W</given-names></name></person-group><year>2005</year><article-title>Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>32618</fpage><lpage>32624</lpage><pub-id pub-id-type="pmid">16046395</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino3"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>Latorre</surname><given-names>V</given-names></name><name><surname>Rubino</surname><given-names>V</given-names></name><name><surname>Rampino</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain.</article-title><source>J Neurosci</source><volume>26</volume><fpage>3918</fpage><lpage>3922</lpage><pub-id pub-id-type="pmid">16611807</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino4"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Caforio</surname><given-names>G</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>De Candia</surname><given-names>M</given-names></name><name><surname>Latorre</surname><given-names>V</given-names></name><etal/></person-group><year>2004</year><article-title>Interaction of COMT Val108/158 Met Genotype and Olanzapine Treatment on Prefrontal Cortical Function in Patients With Schizophrenia.</article-title><source>Am J Psychiatry</source><volume>161</volume><fpage>1798</fpage><lpage>1805</lpage><pub-id pub-id-type="pmid">15465976</pub-id></mixed-citation></ref><ref id="pone.0009348-Catafau1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catafau</surname><given-names>AM</given-names></name><name><surname>Tolosa</surname><given-names>E</given-names></name></person-group><year>2004</year><article-title>Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.</article-title><source>Mov Disord</source><volume>19</volume><fpage>1175</fpage><lpage>1182</lpage><pub-id pub-id-type="pmid">15390019</pub-id></mixed-citation></ref><ref id="pone.0009348-Booij1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booij</surname><given-names>J</given-names></name><name><surname>Hemelaar</surname><given-names>TG</given-names></name><name><surname>Speelman</surname><given-names>JD</given-names></name><name><surname>de Bruin</surname><given-names>K</given-names></name><name><surname>Janssen</surname><given-names>AG</given-names></name><etal/></person-group><year>1999</year><article-title>One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by &#x0005b;123I&#x0005d;FPCIT SPECT.</article-title><source>J Nucl Med</source><volume>40</volume><fpage>753</fpage><lpage>761</lpage><pub-id pub-id-type="pmid">10319746</pub-id></mixed-citation></ref><ref id="pone.0009348-Meyer1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>PT</given-names></name><name><surname>Sattler</surname><given-names>B</given-names></name><name><surname>Winz</surname><given-names>OH</given-names></name><name><surname>Fundke</surname><given-names>R</given-names></name><name><surname>Oehlwein</surname><given-names>C</given-names></name><etal/></person-group><year>2008</year><article-title>Kinetic analyses of &#x0005b;123I&#x0005d;IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.</article-title><source>Neuroimage</source><volume>42</volume><fpage>548</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">18595739</pub-id></mixed-citation></ref><ref id="pone.0009348-Seibyl1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibyl</surname><given-names>J</given-names></name><name><surname>Jennings</surname><given-names>D</given-names></name><name><surname>Tabamo</surname><given-names>R</given-names></name><name><surname>Marek</surname><given-names>K</given-names></name></person-group><year>2005</year><article-title>Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease research.</article-title><source>Q J Nucl Med Mol Imaging</source><volume>49</volume><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">16010256</pub-id></mixed-citation></ref><ref id="pone.0009348-Brucke1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brucke</surname><given-names>T</given-names></name><name><surname>Podreka</surname><given-names>I</given-names></name><name><surname>Angelberger</surname><given-names>P</given-names></name><name><surname>Wenger</surname><given-names>S</given-names></name><name><surname>Topitz</surname><given-names>A</given-names></name><etal/></person-group><year>1991</year><article-title>Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.</article-title><source>J Cereb Blood Flow Metab</source><volume>11</volume><fpage>220</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">1671782</pub-id></mixed-citation></ref><ref id="pone.0009348-Tatsch1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatsch</surname><given-names>K</given-names></name><name><surname>Asenbaum</surname><given-names>S</given-names></name><name><surname>Bartenstein</surname><given-names>P</given-names></name><name><surname>Catafau</surname><given-names>A</given-names></name><name><surname>Halldin</surname><given-names>C</given-names></name><etal/></person-group><year>2002</year><article-title>European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.</article-title><source>Eur J Nucl Med Mol Imaging</source><volume>29</volume><fpage>BP23</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">12436495</pub-id></mixed-citation></ref><ref id="pone.0009348-Soret1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soret</surname><given-names>M</given-names></name><name><surname>Koulibaly</surname><given-names>PM</given-names></name><name><surname>Darcourt</surname><given-names>J</given-names></name><name><surname>Hapdey</surname><given-names>S</given-names></name><name><surname>Buvat</surname><given-names>I</given-names></name></person-group><year>2003</year><article-title>Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT.</article-title><source>J Nucl Med</source><volume>44</volume><fpage>1184</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">12843235</pub-id></mixed-citation></ref><ref id="pone.0009348-Laruelle1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laruelle</surname><given-names>M</given-names></name><name><surname>Baldwin</surname><given-names>RM</given-names></name><name><surname>Innis</surname><given-names>RB</given-names></name></person-group><year>1994</year><article-title>SPECT imaging of dopamine and serotonin transporters in nonhuman primate brain.</article-title><source>NIDA Res Monogr</source><volume>138</volume><fpage>131</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">7603539</pub-id></mixed-citation></ref><ref id="pone.0009348-Frankle1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankle</surname><given-names>WG</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><name><surname>Hackett</surname><given-names>E</given-names></name><name><surname>Mawlawi</surname><given-names>O</given-names></name><name><surname>Zea-Ponce</surname><given-names>Y</given-names></name><etal/></person-group><year>2004</year><article-title>Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.</article-title><source>Psychopharmacology (Berl)</source><volume>175</volume><fpage>473</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">15083259</pub-id></mixed-citation></ref><ref id="pone.0009348-Scherfler1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherfler</surname><given-names>C</given-names></name><name><surname>Seppi</surname><given-names>K</given-names></name><name><surname>Donnemiller</surname><given-names>E</given-names></name><name><surname>Goebel</surname><given-names>G</given-names></name><name><surname>Brenneis</surname><given-names>C</given-names></name><etal/></person-group><year>2005</year><article-title>Voxel-wise analysis of &#x0005b;123I&#x0005d;beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.</article-title><source>Brain</source><volume>128</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="pmid">15817519</pub-id></mixed-citation></ref><ref id="pone.0009348-Lidow1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lidow</surname><given-names>MS</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name><name><surname>Rakic</surname><given-names>P</given-names></name><name><surname>Innis</surname><given-names>RB</given-names></name></person-group><year>1989</year><article-title>Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with &#x0005b;3H&#x0005d;raclopride.</article-title><source>Proc Natl Acad Sci U S A</source><volume>86</volume><fpage>6412</fpage><lpage>6416</lpage><pub-id pub-id-type="pmid">2548214</pub-id></mixed-citation></ref><ref id="pone.0009348-Lewis1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Melchitzky</surname><given-names>DS</given-names></name><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Whitehead</surname><given-names>RE</given-names></name><name><surname>Auh</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization.</article-title><source>J Comp Neurol</source><volume>432</volume><fpage>119</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">11241381</pub-id></mixed-citation></ref><ref id="pone.0009348-Laruelle2"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laruelle</surname><given-names>M</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>van Dyck</surname><given-names>CH</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><name><surname>D'Souza</surname><given-names>CD</given-names></name><etal/></person-group><year>1996</year><article-title>Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>9235</fpage><lpage>9240</lpage><pub-id pub-id-type="pmid">8799184</pub-id></mixed-citation></ref><ref id="pone.0009348-Seibyl2"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibyl</surname><given-names>JP</given-names></name><name><surname>Woods</surname><given-names>SW</given-names></name><name><surname>Zoghbi</surname><given-names>SS</given-names></name><name><surname>Baldwin</surname><given-names>RM</given-names></name><name><surname>Dey</surname><given-names>HM</given-names></name><etal/></person-group><year>1992</year><article-title>Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM.</article-title><source>J Nucl Med</source><volume>33</volume><fpage>1964</fpage><lpage>1971</lpage><pub-id pub-id-type="pmid">1432157</pub-id></mixed-citation></ref><ref id="pone.0009348-Beukers1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beukers</surname><given-names>RJ</given-names></name><name><surname>Booij</surname><given-names>J</given-names></name><name><surname>Weisscher</surname><given-names>N</given-names></name><name><surname>Zijlstra</surname><given-names>F</given-names></name><name><surname>van Amelsvoort</surname><given-names>TA</given-names></name><etal/></person-group><year>2009</year><article-title>Reduced striatal D2 receptor binding in myoclonus-dystonia.</article-title><source>Eur J Nucl Med Mol Imaging</source><volume>36</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">18719906</pub-id></mixed-citation></ref><ref id="pone.0009348-Verhoeff1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhoeff</surname><given-names>NP</given-names></name><name><surname>Kapucu</surname><given-names>O</given-names></name><name><surname>Sokole-Busemann</surname><given-names>E</given-names></name><name><surname>van Royen</surname><given-names>EA</given-names></name><name><surname>Janssen</surname><given-names>AG</given-names></name></person-group><year>1993</year><article-title>Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.</article-title><source>J Nucl Med</source><volume>34</volume><fpage>2076</fpage><lpage>2084</lpage><pub-id pub-id-type="pmid">8254390</pub-id></mixed-citation></ref><ref id="pone.0009348-Lancaster1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname><given-names>JL</given-names></name><name><surname>Woldorff</surname><given-names>MG</given-names></name><name><surname>Parsons</surname><given-names>LM</given-names></name><name><surname>Liotti</surname><given-names>M</given-names></name><name><surname>Freitas</surname><given-names>CS</given-names></name><etal/></person-group><year>2000</year><article-title>Automated Talairach atlas labels for functional brain mapping.</article-title><source>Hum Brain Mapp</source><volume>10</volume><fpage>120</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">10912591</pub-id></mixed-citation></ref><ref id="pone.0009348-Maldjian1"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldjian</surname><given-names>JA</given-names></name><name><surname>Laurienti</surname><given-names>PJ</given-names></name><name><surname>Kraft</surname><given-names>RA</given-names></name><name><surname>Burdette</surname><given-names>JH</given-names></name></person-group><year>2003</year><article-title>An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.</article-title><source>Neuroimage</source><volume>19</volume><fpage>1233</fpage><lpage>1239</lpage><pub-id pub-id-type="pmid">12880848</pub-id></mixed-citation></ref><ref id="pone.0009348-TzourioMazoyer1"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzourio-Mazoyer</surname><given-names>N</given-names></name><name><surname>Landeau</surname><given-names>B</given-names></name><name><surname>Papathanassiou</surname><given-names>D</given-names></name><name><surname>Crivello</surname><given-names>F</given-names></name><name><surname>Etard</surname><given-names>O</given-names></name><etal/></person-group><year>2002</year><article-title>Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.</article-title><source>Neuroimage</source><volume>15</volume><fpage>273</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">11771995</pub-id></mixed-citation></ref><ref id="pone.0009348-Rakshi1"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakshi</surname><given-names>JS</given-names></name><name><surname>Uema</surname><given-names>T</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Bailey</surname><given-names>DL</given-names></name><name><surname>Morrish</surname><given-names>PK</given-names></name><etal/></person-group><year>1999</year><article-title>Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D &#x0005b;(18)F&#x0005d;dopa-PET study.</article-title><source>Brain</source><volume>122 (Pt 9)</volume><fpage>1637</fpage><lpage>1650</lpage><pub-id pub-id-type="pmid">10468504</pub-id></mixed-citation></ref><ref id="pone.0009348-Laruelle3"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laruelle</surname><given-names>M</given-names></name><name><surname>Baldwin</surname><given-names>RM</given-names></name><name><surname>Malison</surname><given-names>RT</given-names></name><name><surname>Zea-Ponce</surname><given-names>Y</given-names></name><name><surname>Zoghbi</surname><given-names>SS</given-names></name><etal/></person-group><year>1993</year><article-title>SPECT imaging of dopamine and serotonin transporters with &#x0005b;123I&#x0005d;beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.</article-title><source>Synapse</source><volume>13</volume><fpage>295</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">7683143</pub-id></mixed-citation></ref><ref id="pone.0009348-Laruelle4"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laruelle</surname><given-names>M</given-names></name><name><surname>D'Souza</surname><given-names>CD</given-names></name><name><surname>Baldwin</surname><given-names>RM</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>Kanes</surname><given-names>SJ</given-names></name><etal/></person-group><year>1997</year><article-title>Imaging D2 receptor occupancy by endogenous dopamine in humans.</article-title><source>Neuropsychopharmacology</source><volume>17</volume><fpage>162</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">9272483</pub-id></mixed-citation></ref><ref id="pone.0009348-Jones1"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>SR</given-names></name><name><surname>Gainetdinov</surname><given-names>RR</given-names></name><name><surname>Hu</surname><given-names>XT</given-names></name><name><surname>Cooper</surname><given-names>DC</given-names></name><name><surname>Wightman</surname><given-names>RM</given-names></name><etal/></person-group><year>1999</year><article-title>Loss of autoreceptor functions in mice lacking the dopamine transporter.</article-title><source>Nat Neurosci</source><volume>2</volume><fpage>649</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">10404198</pub-id></mixed-citation></ref><ref id="pone.0009348-HIll1"><label>64</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>HIll</surname><given-names>T</given-names></name><name><surname>Lewicki</surname><given-names>P</given-names></name></person-group><year>2006</year><article-title>Statistics: methods and applications.</article-title><comment>A comprehensive reference for science, industry, and data mining: StatSofr Inc</comment></mixed-citation></ref><ref id="pone.0009348-Callicott2"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Finn</surname><given-names>K</given-names></name><name><surname>Coppola</surname><given-names>R</given-names></name><etal/></person-group><year>1999</year><article-title>Physiological characteristics of capacity constraints in working memory as revealed by functional MRI.</article-title><source>Cereb Cortex</source><volume>9</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10022492</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino5"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Blasi</surname><given-names>G</given-names></name><name><surname>Caforio</surname><given-names>G</given-names></name><name><surname>Latorre</surname><given-names>V</given-names></name><name><surname>De Candia</surname><given-names>M</given-names></name><etal/></person-group><year>2004</year><article-title>Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine.</article-title><source>Biol Psychiatry</source><volume>56</volume><fpage>190</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">15271588</pub-id></mixed-citation></ref><ref id="pone.0009348-Curtis1"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>CE</given-names></name><name><surname>Rao</surname><given-names>VY</given-names></name><name><surname>D'Esposito</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>Maintenance of spatial and motor codes during oculomotor delayed response tasks.</article-title><source>J Neurosci</source><volume>24</volume><fpage>3944</fpage><lpage>3952</lpage><pub-id pub-id-type="pmid">15102910</pub-id></mixed-citation></ref><ref id="pone.0009348-Tan1"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>HY</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory.</article-title><source>J Neurosci</source><volume>27</volume><fpage>13393</fpage><lpage>13401</lpage><pub-id pub-id-type="pmid">18057197</pub-id></mixed-citation></ref><ref id="pone.0009348-Manoach2"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoach</surname><given-names>DS</given-names></name><name><surname>White</surname><given-names>NS</given-names></name><name><surname>Lindgren</surname><given-names>KA</given-names></name><name><surname>Heckers</surname><given-names>S</given-names></name><name><surname>Coleman</surname><given-names>MJ</given-names></name><etal/></person-group><year>2004</year><article-title>Hemispheric specialization of the lateral prefrontal cortex for strategic processing during spatial and shape working memory.</article-title><source>Neuroimage</source><volume>21</volume><fpage>894</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">15006656</pub-id></mixed-citation></ref><ref id="pone.0009348-Williams1"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Castner</surname><given-names>SA</given-names></name></person-group><year>2006</year><article-title>Under the curve: critical issues for elucidating D1 receptor function in working memory.</article-title><source>Neuroscience</source><volume>139</volume><fpage>263</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">16310964</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino6"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Caforio</surname><given-names>G</given-names></name><name><surname>Petruzzella</surname><given-names>V</given-names></name><name><surname>Latorre</surname><given-names>V</given-names></name><name><surname>Rubino</surname><given-names>V</given-names></name><etal/></person-group><year>2006</year><article-title>Prefrontal dysfunction in schizophrenia controlling for COMT Val(158)Met genotype and working memory performance.</article-title><source>Psychiatry Res</source><volume>147</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">16952445</pub-id></mixed-citation></ref><ref id="pone.0009348-Callicott3"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Langheim</surname><given-names>FJ</given-names></name><name><surname>Duyn</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.</article-title><source>Cereb Cortex</source><volume>10</volume><fpage>1078</fpage><lpage>1092</lpage><pub-id pub-id-type="pmid">11053229</pub-id></mixed-citation></ref><ref id="pone.0009348-Hirvonen1"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirvonen</surname><given-names>MM</given-names></name><name><surname>Nagren</surname><given-names>K</given-names></name><name><surname>Rinne</surname><given-names>JO</given-names></name><name><surname>Pesonen</surname><given-names>U</given-names></name><name><surname>Vahlberg</surname><given-names>T</given-names></name><etal/></person-group><year>2009</year><article-title>COMT Val158Met Genotype Does Not Alter Cortical or Striatal Dopamine D2 Receptor.</article-title><source>Availability In Vivo Mol Imaging Biol</source></mixed-citation></ref><ref id="pone.0009348-AbiDargham1"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>Rodenhiser</surname><given-names>J</given-names></name><name><surname>Printz</surname><given-names>D</given-names></name><name><surname>Zea-Ponce</surname><given-names>Y</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><etal/></person-group><year>2000</year><article-title>Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>8104</fpage><lpage>8109</lpage><pub-id pub-id-type="pmid">10884434</pub-id></mixed-citation></ref><ref id="pone.0009348-Guo1"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Kralikova</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Schieren</surname><given-names>I</given-names></name><etal/></person-group><year>2009</year><article-title>Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers.</article-title><source>Neuropsychopharmacology</source></mixed-citation></ref><ref id="pone.0009348-Jonsson1"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>EG</given-names></name><name><surname>Nothen</surname><given-names>MM</given-names></name><name><surname>Neidt</surname><given-names>H</given-names></name><name><surname>Forslund</surname><given-names>K</given-names></name><name><surname>Rylander</surname><given-names>G</given-names></name><etal/></person-group><year>1999</year><article-title>Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.</article-title><source>Schizophr Res</source><volume>40</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10541004</pub-id></mixed-citation></ref><ref id="pone.0009348-Pohjalainen1"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohjalainen</surname><given-names>T</given-names></name><name><surname>Rinne</surname><given-names>JO</given-names></name><name><surname>Nagren</surname><given-names>K</given-names></name><name><surname>Lehikoinen</surname><given-names>P</given-names></name><name><surname>Anttila</surname><given-names>K</given-names></name><etal/></person-group><year>1998</year><article-title>The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.</article-title><source>Mol Psychiatry</source><volume>3</volume><fpage>256</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">9672901</pub-id></mixed-citation></ref><ref id="pone.0009348-Ritchie1"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>T</given-names></name><name><surname>Noble</surname><given-names>EP</given-names></name></person-group><year>2003</year><article-title>Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.</article-title><source>Neurochem Res</source><volume>28</volume><fpage>73</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">12587665</pub-id></mixed-citation></ref><ref id="pone.0009348-Calabresi1"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabresi</surname><given-names>P</given-names></name><name><surname>Pisani</surname><given-names>A</given-names></name><name><surname>Mercuri</surname><given-names>NB</given-names></name><name><surname>Bernardi</surname><given-names>G</given-names></name></person-group><year>1996</year><article-title>The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia.</article-title><source>Trends Neurosci</source><volume>19</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8787136</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino7"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Knable</surname><given-names>MB</given-names></name><name><surname>Saunders</surname><given-names>RC</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Kolachana</surname><given-names>B</given-names></name><etal/></person-group><year>1999</year><article-title>The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.</article-title><source>Biol Psychiatry</source><volume>45</volume><fpage>660</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">10187995</pub-id></mixed-citation></ref><ref id="pone.0009348-Bertolino8"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Breier</surname><given-names>A</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Adler</surname><given-names>C</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><etal/></person-group><year>2000</year><article-title>The relationship between dorsolateral prefrontal neuronal N- acetylaspartate and evoked release of striatal dopamine in schizophrenia.</article-title><source>Neuropsychopharmacology</source><volume>22</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">10649825</pub-id></mixed-citation></ref><ref id="pone.0009348-MeyerLindenberg1"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Miletich</surname><given-names>RS</given-names></name><name><surname>Kohn</surname><given-names>PD</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Carson</surname><given-names>RE</given-names></name><etal/></person-group><year>2002</year><article-title>Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.</article-title><source>Nat Neurosci</source><volume>5</volume><fpage>267</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">11865311</pub-id></mixed-citation></ref><ref id="pone.0009348-Huttunen1"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttunen</surname><given-names>J</given-names></name><name><surname>Heinimaa</surname><given-names>M</given-names></name><name><surname>Svirskis</surname><given-names>T</given-names></name><name><surname>Nyman</surname><given-names>M</given-names></name><name><surname>Kajander</surname><given-names>J</given-names></name><etal/></person-group><year>2008</year><article-title>Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia.</article-title><source>Biol Psychiatry</source><volume>63</volume><fpage>114</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">17655830</pub-id></mixed-citation></ref><ref id="pone.0009348-Hirvonen2"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirvonen</surname><given-names>J</given-names></name><name><surname>van Erp</surname><given-names>TG</given-names></name><name><surname>Huttunen</surname><given-names>J</given-names></name><name><surname>Aalto</surname><given-names>S</given-names></name><name><surname>Nagren</surname><given-names>K</given-names></name><etal/></person-group><year>2005</year><article-title>Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.</article-title><source>Arch Gen Psychiatry</source><volume>62</volume><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">15809404</pub-id></mixed-citation></ref><ref id="pone.0009348-Howes1"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howes</surname><given-names>OD</given-names></name><name><surname>Montgomery</surname><given-names>AJ</given-names></name><name><surname>Asselin</surname><given-names>MC</given-names></name><name><surname>Murray</surname><given-names>RM</given-names></name><name><surname>Valli</surname><given-names>I</given-names></name><etal/></person-group><year>2009</year><article-title>Elevated striatal dopamine function linked to prodromal signs of schizophrenia.</article-title><source>Arch Gen Psychiatry</source><volume>66</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">19124684</pub-id></mixed-citation></ref><ref id="pone.0009348-Callicott4"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Bone</surname><given-names>AD</given-names></name><etal/></person-group><year>2003</year><article-title>Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia.</article-title><source>Am J Psychiatry</source><volume>160</volume><fpage>709</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">12668360</pub-id></mixed-citation></ref><ref id="pone.0009348-Seidman1"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidman</surname><given-names>LJ</given-names></name><name><surname>Thermenos</surname><given-names>HW</given-names></name><name><surname>Poldrack</surname><given-names>RA</given-names></name><name><surname>Peace</surname><given-names>NK</given-names></name><name><surname>Koch</surname><given-names>JK</given-names></name><etal/></person-group><year>2006</year><article-title>Altered brain activation in dorsolateral prefrontal cortex in adolescents and young adults at genetic risk for schizophrenia: an fMRI study of working memory.</article-title><source>Schizophr Res</source><volume>85</volume><fpage>58</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16632333</pub-id></mixed-citation></ref><ref id="pone.0009348-Lewis2"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>CM</given-names></name><name><surname>Levinson</surname><given-names>DF</given-names></name><name><surname>Wise</surname><given-names>LH</given-names></name><name><surname>DeLisi</surname><given-names>LE</given-names></name><name><surname>Straub</surname><given-names>RE</given-names></name><etal/></person-group><year>2003</year><article-title>Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.</article-title><source>Am J Hum Genet</source><volume>73</volume><fpage>34</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">12802786</pub-id></mixed-citation></ref><ref id="pone.0009348-Betcheva1"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betcheva</surname><given-names>ET</given-names></name><name><surname>Mushiroda</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Karachanak</surname><given-names>SK</given-names></name><etal/></person-group><year>2009</year><article-title>Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population.</article-title><source>J Hum Genet</source><volume>54</volume><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">19158809</pub-id></mixed-citation></ref><ref id="pone.0009348-Glatt2"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Lasky-Su</surname><given-names>JA</given-names></name><name><surname>Kanazawa</surname><given-names>T</given-names></name><name><surname>Hwu</surname><given-names>HG</given-names></name><etal/></person-group><year>2008</year><article-title>Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan.</article-title><source>Mol Psychiatry</source></mixed-citation></ref><ref id="pone.0009348-Catafau2"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catafau</surname><given-names>AM</given-names></name><name><surname>Bullich</surname><given-names>S</given-names></name><name><surname>Danus</surname><given-names>M</given-names></name><name><surname>Penengo</surname><given-names>MM</given-names></name><name><surname>Cot</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.</article-title><source>Synapse</source><volume>62</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">17960766</pub-id></mixed-citation></ref><ref id="pone.0009348-Kegeles1"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kegeles</surname><given-names>LS</given-names></name><name><surname>Zea-Ponce</surname><given-names>Y</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>Rodenhiser</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Stability of &#x0005b;123I&#x0005d;IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.</article-title><source>Synapse</source><volume>31</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">10051112</pub-id></mixed-citation></ref><ref id="pone.0009348-Tsuchida1"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchida</surname><given-names>T</given-names></name><name><surname>Ballinger</surname><given-names>JR</given-names></name><name><surname>Vines</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Utsunomiya</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients.</article-title><source>Ann Nucl Med</source><volume>18</volume><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">15586635</pub-id></mixed-citation></ref><ref id="pone.0009348-Manoach3"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoach</surname><given-names>DS</given-names></name><name><surname>Halpern</surname><given-names>EF</given-names></name><name><surname>Kramer</surname><given-names>TS</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Goff</surname><given-names>DC</given-names></name><etal/></person-group><year>2001</year><article-title>Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects.</article-title><source>Am J Psychiatry</source><volume>158</volume><fpage>955</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">11384907</pub-id></mixed-citation></ref><ref id="pone.0009348-Caceres1"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caceres</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>DL</given-names></name><name><surname>Zelaya</surname><given-names>FO</given-names></name><name><surname>Williams</surname><given-names>SC</given-names></name><name><surname>Mehta</surname><given-names>MA</given-names></name></person-group><year>2009</year><article-title>Measuring fMRI reliability with the intra-class correlation coefficient.</article-title><source>Neuroimage</source><volume>45</volume><fpage>758</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">19166942</pub-id></mixed-citation></ref><ref id="pone.0009348-Wei1"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Yoo</surname><given-names>SS</given-names></name><name><surname>Dickey</surname><given-names>CC</given-names></name><name><surname>Zou</surname><given-names>KH</given-names></name><name><surname>Guttmann</surname><given-names>CR</given-names></name><etal/></person-group><year>2004</year><article-title>Functional MRI of auditory verbal working memory: long-term reproducibility analysis.</article-title><source>Neuroimage</source><volume>21</volume><fpage>1000</fpage><lpage>1008</lpage><pub-id pub-id-type="pmid">15006667</pub-id></mixed-citation></ref><ref id="pone.0009348-Ishikawa1"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Dhawan</surname><given-names>V</given-names></name><name><surname>Kazumata</surname><given-names>K</given-names></name><name><surname>Chaly</surname><given-names>T</given-names></name><name><surname>Mandel</surname><given-names>F</given-names></name><etal/></person-group><year>1996</year><article-title>Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.</article-title><source>J Nucl Med</source><volume>37</volume><fpage>1760</fpage><lpage>1765</lpage><pub-id pub-id-type="pmid">8917170</pub-id></mixed-citation></ref><ref id="pone.0009348-Booij2"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booij</surname><given-names>J</given-names></name><name><surname>Bergmans</surname><given-names>P</given-names></name><name><surname>Winogrodzka</surname><given-names>A</given-names></name><name><surname>Speelman</surname><given-names>JD</given-names></name><name><surname>Wolters</surname><given-names>EC</given-names></name></person-group><year>2001</year><article-title>Imaging of dopamine transporters with &#x0005b;123I&#x0005d;FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.</article-title><source>Synapse</source><volume>39</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">11180497</pub-id></mixed-citation></ref><ref id="pone.0009348-Volkow2"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>ND</given-names></name><name><surname>Ding</surname><given-names>YS</given-names></name><name><surname>Fowler</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>GJ</given-names></name><name><surname>Logan</surname><given-names>J</given-names></name><etal/></person-group><year>1996</year><article-title>Dopamine transporters decrease with age.</article-title><source>J Nucl Med</source><volume>37</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">8691238</pub-id></mixed-citation></ref><ref id="pone.0009348-Chen1"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>PS</given-names></name><name><surname>Yang</surname><given-names>YK</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Yeh</surname><given-names>TL</given-names></name><name><surname>Lee</surname><given-names>IH</given-names></name><etal/></person-group><year>2005</year><article-title>Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study.</article-title><source>Psychol Med</source><volume>35</volume><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">15841677</pub-id></mixed-citation></ref><ref id="pone.0009348-Volkow3"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>ND</given-names></name><name><surname>Wang</surname><given-names>GJ</given-names></name><name><surname>Fowler</surname><given-names>JS</given-names></name><name><surname>Logan</surname><given-names>J</given-names></name><name><surname>Gatley</surname><given-names>SJ</given-names></name><etal/></person-group><year>1996</year><article-title>Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.</article-title><source>Psychiatry Res</source><volume>67</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">8797238</pub-id></mixed-citation></ref><ref id="pone.0009348-MeyerLindenberg2"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Nicodemus</surname><given-names>KK</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mattay</surname><given-names>V</given-names></name><etal/></person-group><year>2008</year><article-title>False positives in imaging genetics.</article-title><source>Neuroimage</source><volume>40</volume><fpage>655</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">18201908</pub-id></mixed-citation></ref><ref id="pone.0009348-MeyerLindenberg3"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Kohn</surname><given-names>PD</given-names></name><name><surname>Kolachana</surname><given-names>B</given-names></name><name><surname>Kippenhan</surname><given-names>S</given-names></name><name><surname>McInerney-Leo</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.</article-title><source>Nat Neurosci</source><volume>8</volume><fpage>594</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">15821730</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Part of this work was supported by a National Institutes of Health (NIH) grant DA022199 (W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>